In the first wave of a four-week online survey tracking changing opinions on Covid-19 in Europe and the USA, the sample compares the answers of healthcare professionals with those of the general public, revealing a more moderate response to a potential outbreak. A total of 3,268 doctors and 687 patients from M3 Global Research’s healthcare panel participated in the survey
Every week we will be sharing results of this report revealing how doctors and patients feel the outbreak is impacting their jobs, society and ultimately lives as the situation continues to unfold.

TAVR matches open-heart surgery durability in low-risk patients, as PARTNER 3 trial seven-year data confirm lasting valve performance.

Mesothelioma trial finds blocking miteochondrial enzym and enzyme in tumour cells controlled disease progression in 67% of patients.

Severe fatty liver disease may be eased as MASH treatment improves gut health, offering a promising new approach beyond the liver.